nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLCO1B1—breast cancer	0.212	0.495	CbGaD
Sulfasalazine—ABCG2—breast cancer	0.0924	0.215	CbGaD
Sulfasalazine—PTGS1—breast cancer	0.0791	0.184	CbGaD
Sulfasalazine—SLC46A1—Methotrexate—breast cancer	0.0722	0.205	CbGbCtD
Sulfasalazine—PTGS2—breast cancer	0.0452	0.105	CbGaD
Sulfasalazine—CYP3A5—Lapatinib—breast cancer	0.0186	0.053	CbGbCtD
Sulfasalazine—ABCC2—Tamoxifen—breast cancer	0.0186	0.0529	CbGbCtD
Sulfasalazine—ABCG2—Tamoxifen—breast cancer	0.0169	0.0479	CbGbCtD
Sulfasalazine—ABCG2—Mitoxantrone—breast cancer	0.0164	0.0467	CbGbCtD
Sulfasalazine—SLCO1B1—Irinotecan—breast cancer	0.0163	0.0463	CbGbCtD
Sulfasalazine—ABCC2—Paclitaxel—breast cancer	0.0145	0.0412	CbGbCtD
Sulfasalazine—ABCC2—Irinotecan—breast cancer	0.0143	0.0407	CbGbCtD
Sulfasalazine—ABCC2—Carboplatin—breast cancer	0.0137	0.0388	CbGbCtD
Sulfasalazine—ABCG2—Paclitaxel—breast cancer	0.0131	0.0373	CbGbCtD
Sulfasalazine—ABCG2—Irinotecan—breast cancer	0.0129	0.0368	CbGbCtD
Sulfasalazine—ABCC2—Vinblastine—breast cancer	0.0127	0.0361	CbGbCtD
Sulfasalazine—ABCG2—Fluorouracil—breast cancer	0.0124	0.0353	CbGbCtD
Sulfasalazine—ABCG2—Carboplatin—breast cancer	0.0123	0.0351	CbGbCtD
Sulfasalazine—ABCC2—Docetaxel—breast cancer	0.0105	0.0298	CbGbCtD
Sulfasalazine—ABCG2—Docetaxel—breast cancer	0.00948	0.0269	CbGbCtD
Sulfasalazine—CYP3A5—Tamoxifen—breast cancer	0.00934	0.0265	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—breast cancer	0.00862	0.0245	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—breast cancer	0.00782	0.0222	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—breast cancer	0.00758	0.0215	CbGbCtD
Sulfasalazine—CYP3A5—Paclitaxel—breast cancer	0.00727	0.0206	CbGbCtD
Sulfasalazine—CYP3A5—Irinotecan—breast cancer	0.00717	0.0204	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—breast cancer	0.00707	0.0201	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—breast cancer	0.00685	0.0195	CbGbCtD
Sulfasalazine—CYP3A5—Docetaxel—breast cancer	0.00525	0.0149	CbGbCtD
Sulfasalazine—TBXAS1—mammary gland—breast cancer	0.00229	0.0375	CbGeAlD
Sulfasalazine—ACAT1—uterus—breast cancer	0.00126	0.0206	CbGeAlD
Sulfasalazine—ACAT1—adipose tissue—breast cancer	0.00123	0.0202	CbGeAlD
Sulfasalazine—IKBKB—nipple—breast cancer	0.00115	0.0188	CbGeAlD
Sulfasalazine—CHUK—epithelium—breast cancer	0.00113	0.0186	CbGeAlD
Sulfasalazine—ACAT1—female reproductive system—breast cancer	0.00113	0.0185	CbGeAlD
Sulfasalazine—PPARG—Topotecan—Irinotecan—breast cancer	0.00113	0.539	CbGdCrCtD
Sulfasalazine—ACAT1—adrenal gland—breast cancer	0.0011	0.0181	CbGeAlD
Sulfasalazine—CHUK—skin of body—breast cancer	0.00108	0.0177	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—breast cancer	0.00107	0.0175	CbGeAlD
Sulfasalazine—PLA2G1B—epithelium—breast cancer	0.00107	0.0175	CbGeAlD
Sulfasalazine—TBXAS1—uterus—breast cancer	0.00105	0.0172	CbGeAlD
Sulfasalazine—ACAT1—female gonad—breast cancer	0.00103	0.0169	CbGeAlD
Sulfasalazine—TBXAS1—adipose tissue—breast cancer	0.00103	0.0169	CbGeAlD
Sulfasalazine—SLCO1B1—mammary gland—breast cancer	0.000999	0.0164	CbGeAlD
Sulfasalazine—ACAT1—endocrine gland—breast cancer	0.000957	0.0157	CbGeAlD
Sulfasalazine—IKBKB—embryo—breast cancer	0.000945	0.0155	CbGeAlD
Sulfasalazine—TBXAS1—adrenal gland—breast cancer	0.000923	0.0151	CbGeAlD
Sulfasalazine—SLC46A1—pituitary gland—breast cancer	0.000921	0.0151	CbGeAlD
Sulfasalazine—CHUK—adipose tissue—breast cancer	0.000917	0.015	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—breast cancer	0.000893	0.0146	CbGeAlD
Sulfasalazine—Olsalazine—IFNG—breast cancer	0.000885	0.299	CrCbGaD
Sulfasalazine—PLA2G1B—pituitary gland—breast cancer	0.000866	0.0142	CbGeAlD
Sulfasalazine—PPARG—mammary gland—breast cancer	0.000862	0.0141	CbGeAlD
Sulfasalazine—CHUK—female reproductive system—breast cancer	0.000843	0.0138	CbGeAlD
Sulfasalazine—CHUK—adrenal gland—breast cancer	0.000823	0.0135	CbGeAlD
Sulfasalazine—SLC46A1—adrenal gland—breast cancer	0.000823	0.0135	CbGeAlD
Sulfasalazine—TBXAS1—endocrine gland—breast cancer	0.0008	0.0131	CbGeAlD
Sulfasalazine—PLA2G1B—female reproductive system—breast cancer	0.000793	0.013	CbGeAlD
Sulfasalazine—PLA2G1B—adrenal gland—breast cancer	0.000773	0.0127	CbGeAlD
Sulfasalazine—CHUK—female gonad—breast cancer	0.000767	0.0126	CbGeAlD
Sulfasalazine—SLC46A1—female gonad—breast cancer	0.000767	0.0126	CbGeAlD
Sulfasalazine—SLC7A11—adipose tissue—breast cancer	0.000755	0.0124	CbGeAlD
Sulfasalazine—IKBKB—skin of body—breast cancer	0.000734	0.012	CbGeAlD
Sulfasalazine—PLA2G1B—female gonad—breast cancer	0.000721	0.0118	CbGeAlD
Sulfasalazine—SLC46A1—endocrine gland—breast cancer	0.000713	0.0117	CbGeAlD
Sulfasalazine—CHUK—endocrine gland—breast cancer	0.000713	0.0117	CbGeAlD
Sulfasalazine—PPARG—nipple—breast cancer	0.000713	0.0117	CbGeAlD
Sulfasalazine—SLC7A11—female reproductive system—breast cancer	0.000694	0.0114	CbGeAlD
Sulfasalazine—IKBKB—endometrium—breast cancer	0.000692	0.0113	CbGeAlD
Sulfasalazine—PLA2G1B—endocrine gland—breast cancer	0.000671	0.011	CbGeAlD
Sulfasalazine—ACAT1—lymph node—breast cancer	0.000662	0.0108	CbGeAlD
Sulfasalazine—IKBKB—uterus—breast cancer	0.000637	0.0104	CbGeAlD
Sulfasalazine—SLC7A11—female gonad—breast cancer	0.000632	0.0103	CbGeAlD
Sulfasalazine—IKBKB—pituitary gland—breast cancer	0.000626	0.0103	CbGeAlD
Sulfasalazine—IKBKB—adipose tissue—breast cancer	0.000623	0.0102	CbGeAlD
Sulfasalazine—PPARG—embryo—breast cancer	0.000588	0.00964	CbGeAlD
Sulfasalazine—SLC7A11—endocrine gland—breast cancer	0.000587	0.00962	CbGeAlD
Sulfasalazine—IKBKB—female reproductive system—breast cancer	0.000573	0.00939	CbGeAlD
Sulfasalazine—IKBKB—adrenal gland—breast cancer	0.000559	0.00916	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—breast cancer	0.000553	0.00906	CbGeAlD
Sulfasalazine—IKBKB—female gonad—breast cancer	0.000521	0.00854	CbGeAlD
Sulfasalazine—ALOX5—adipose tissue—breast cancer	0.000517	0.00846	CbGeAlD
Sulfasalazine—CHUK—lymph node—breast cancer	0.000493	0.00808	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—breast cancer	0.000493	0.00808	CbGeAlD
Sulfasalazine—IKBKB—endocrine gland—breast cancer	0.000485	0.00794	CbGeAlD
Sulfasalazine—SLC7A11—Dexamethasone—Fluoxymesterone—breast cancer	0.000484	0.231	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Fluoxymesterone—breast cancer	0.000484	0.231	CbGdCrCtD
Sulfasalazine—PPARG—epithelium—breast cancer	0.00048	0.00786	CbGeAlD
Sulfasalazine—ALOX5—female reproductive system—breast cancer	0.000475	0.00778	CbGeAlD
Sulfasalazine—ALOX5—adrenal gland—breast cancer	0.000463	0.00759	CbGeAlD
Sulfasalazine—PPARG—skin of body—breast cancer	0.000457	0.00748	CbGeAlD
Sulfasalazine—ALOX5—bone marrow—breast cancer	0.000448	0.00734	CbGeAlD
Sulfasalazine—ALOX5—female gonad—breast cancer	0.000432	0.00708	CbGeAlD
Sulfasalazine—SLCO1B1—female reproductive system—breast cancer	0.000413	0.00677	CbGeAlD
Sulfasalazine—ALOX5—endocrine gland—breast cancer	0.000402	0.00658	CbGeAlD
Sulfasalazine—PPARG—uterus—breast cancer	0.000397	0.0065	CbGeAlD
Sulfasalazine—PPARG—adipose tissue—breast cancer	0.000388	0.00636	CbGeAlD
Sulfasalazine—PTGS1—nipple—breast cancer	0.000381	0.00624	CbGeAlD
Sulfasalazine—Balsalazide—PTGS1—breast cancer	0.000362	0.123	CrCbGaD
Sulfasalazine—PPARG—female reproductive system—breast cancer	0.000357	0.00584	CbGeAlD
Sulfasalazine—SLCO1B1—endocrine gland—breast cancer	0.00035	0.00573	CbGeAlD
Sulfasalazine—PPARG—adrenal gland—breast cancer	0.000348	0.0057	CbGeAlD
Sulfasalazine—PPARG—bone marrow—breast cancer	0.000337	0.00551	CbGeAlD
Sulfasalazine—IKBKB—lymph node—breast cancer	0.000335	0.00549	CbGeAlD
Sulfasalazine—PPARG—female gonad—breast cancer	0.000324	0.00532	CbGeAlD
Sulfasalazine—Vismodegib—ABCG2—breast cancer	0.000315	0.107	CrCbGaD
Sulfasalazine—ABCC2—female reproductive system—breast cancer	0.000313	0.00513	CbGeAlD
Sulfasalazine—Olsalazine—PTGS1—breast cancer	0.000308	0.104	CrCbGaD
Sulfasalazine—ABCC2—adrenal gland—breast cancer	0.000306	0.00501	CbGeAlD
Sulfasalazine—PPARG—endocrine gland—breast cancer	0.000302	0.00494	CbGeAlD
Sulfasalazine—PTGS2—embryo—breast cancer	0.000301	0.00492	CbGeAlD
Sulfasalazine—ALOX5—lymph node—breast cancer	0.000278	0.00455	CbGeAlD
Sulfasalazine—ABCG2—endometrium—breast cancer	0.000276	0.00452	CbGeAlD
Sulfasalazine—ABCC2—endocrine gland—breast cancer	0.000265	0.00434	CbGeAlD
Sulfasalazine—PTGS1—epithelium—breast cancer	0.000257	0.0042	CbGeAlD
Sulfasalazine—ABCG2—uterus—breast cancer	0.000254	0.00417	CbGeAlD
Sulfasalazine—ABCG2—pituitary gland—breast cancer	0.00025	0.00409	CbGeAlD
Sulfasalazine—ABCG2—adipose tissue—breast cancer	0.000249	0.00407	CbGeAlD
Sulfasalazine—PTGS2—epithelium—breast cancer	0.000245	0.00402	CbGeAlD
Sulfasalazine—PTGS1—skin of body—breast cancer	0.000244	0.004	CbGeAlD
Sulfasalazine—PTGS2—skin of body—breast cancer	0.000233	0.00382	CbGeAlD
Sulfasalazine—CYP3A5—adipose tissue—breast cancer	0.000231	0.00378	CbGeAlD
Sulfasalazine—PTGS1—endometrium—breast cancer	0.00023	0.00377	CbGeAlD
Sulfasalazine—ABCG2—adrenal gland—breast cancer	0.000223	0.00365	CbGeAlD
Sulfasalazine—PTGS2—endometrium—breast cancer	0.00022	0.0036	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—breast cancer	0.000216	0.00353	CbGeAlD
Sulfasalazine—PTGS1—uterus—breast cancer	0.000212	0.00347	CbGeAlD
Sulfasalazine—PPARG—lymph node—breast cancer	0.000209	0.00342	CbGeAlD
Sulfasalazine—PTGS1—pituitary gland—breast cancer	0.000208	0.00341	CbGeAlD
Sulfasalazine—ABCG2—female gonad—breast cancer	0.000208	0.00341	CbGeAlD
Sulfasalazine—PTGS1—adipose tissue—breast cancer	0.000207	0.0034	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—breast cancer	0.000207	0.0701	CrCbGaD
Sulfasalazine—PTGS2—uterus—breast cancer	0.000203	0.00332	CbGeAlD
Sulfasalazine—PTGS2—pituitary gland—breast cancer	0.000199	0.00326	CbGeAlD
Sulfasalazine—PTGS2—adipose tissue—breast cancer	0.000198	0.00325	CbGeAlD
Sulfasalazine—CYP3A5—female gonad—breast cancer	0.000193	0.00316	CbGeAlD
Sulfasalazine—PTGS1—female reproductive system—breast cancer	0.000191	0.00312	CbGeAlD
Sulfasalazine—PTGS1—adrenal gland—breast cancer	0.000186	0.00305	CbGeAlD
Sulfasalazine—ABCC2—lymph node—breast cancer	0.000183	0.003	CbGeAlD
Sulfasalazine—PTGS2—female reproductive system—breast cancer	0.000182	0.00298	CbGeAlD
Sulfasalazine—CYP3A5—endocrine gland—breast cancer	0.00018	0.00294	CbGeAlD
Sulfasalazine—PTGS2—adrenal gland—breast cancer	0.000178	0.00291	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—breast cancer	0.000176	0.0596	CrCbGaD
Sulfasalazine—PTGS1—female gonad—breast cancer	0.000173	0.00284	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—breast cancer	0.000172	0.00282	CbGeAlD
Sulfasalazine—PTGS2—female gonad—breast cancer	0.000166	0.00272	CbGeAlD
Sulfasalazine—PTGS1—endocrine gland—breast cancer	0.000161	0.00264	CbGeAlD
Sulfasalazine—Vismodegib—CYP3A4—breast cancer	0.000158	0.0533	CrCbGaD
Sulfasalazine—PTGS2—endocrine gland—breast cancer	0.000154	0.00253	CbGeAlD
Sulfasalazine—Sulfaphenazole—CYP2D6—breast cancer	0.000142	0.0481	CrCbGaD
Sulfasalazine—Vismodegib—ALB—breast cancer	0.000138	0.0465	CrCbGaD
Sulfasalazine—ABCG2—lymph node—breast cancer	0.000134	0.00219	CbGeAlD
Sulfasalazine—Sulfadiazine—CYP3A4—breast cancer	0.000133	0.0451	CrCbGaD
Sulfasalazine—Vismodegib—ABCB1—breast cancer	0.000131	0.0444	CrCbGaD
Sulfasalazine—PTGS1—lymph node—breast cancer	0.000112	0.00183	CbGeAlD
Sulfasalazine—PTGS2—lymph node—breast cancer	0.000107	0.00175	CbGeAlD
Sulfasalazine—IKBKB—Immune System—CDKN1B—breast cancer	1.71e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTHFR—breast cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LEP—breast cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TERT—breast cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CG—breast cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK8—breast cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—breast cancer	1.69e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APC—breast cancer	1.69e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CG—breast cancer	1.69e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—breast cancer	1.69e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—breast cancer	1.69e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CAV1—breast cancer	1.68e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—breast cancer	1.68e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGF—breast cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—breast cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KDR—breast cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCB1—breast cancer	1.66e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—COMT—breast cancer	1.66e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CAV1—breast cancer	1.66e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CB—breast cancer	1.65e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTP1—breast cancer	1.65e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGFR1—breast cancer	1.65e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—breast cancer	1.65e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CTNNB1—breast cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—breast cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TYMS—breast cancer	1.63e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HMOX1—breast cancer	1.63e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PIK3CA—breast cancer	1.63e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HIF1A—breast cancer	1.63e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JUN—breast cancer	1.63e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ITPR1—breast cancer	1.62e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ESR1—breast cancer	1.62e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NCOR1—breast cancer	1.61e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PLA2G4A—breast cancer	1.61e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—breast cancer	1.61e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTNNB1—breast cancer	1.61e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SRC—breast cancer	1.61e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1A—breast cancer	1.6e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FN1—breast cancer	1.6e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTEN—breast cancer	1.6e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—BRAF—breast cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NFKBIA—breast cancer	1.58e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.58e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1A—breast cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CG—breast cancer	1.57e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CAV1—breast cancer	1.57e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTEN—breast cancer	1.57e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOTCH1—breast cancer	1.57e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MAPK3—breast cancer	1.57e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCB1—breast cancer	1.56e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—breast cancer	1.56e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—breast cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1—breast cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT2—breast cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GPX1—breast cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK8—breast cancer	1.54e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APC—breast cancer	1.53e-06	1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—breast cancer	1.53e-06	1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CG—breast cancer	1.53e-06	1e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TYMS—breast cancer	1.53e-06	1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP1A1—breast cancer	1.53e-06	1e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MYC—breast cancer	1.53e-06	9.98e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ERCC2—breast cancer	1.52e-06	9.93e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGF—breast cancer	1.52e-06	9.93e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PLA2G4A—breast cancer	1.52e-06	9.92e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—breast cancer	1.52e-06	9.92e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NCOR1—breast cancer	1.52e-06	9.92e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CG—breast cancer	1.51e-06	9.88e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—breast cancer	1.49e-06	9.77e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CD—breast cancer	1.49e-06	9.77e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CD—breast cancer	1.49e-06	9.74e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SRC—breast cancer	1.48e-06	9.71e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK3—breast cancer	1.48e-06	9.69e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS2—breast cancer	1.48e-06	9.67e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—breast cancer	1.47e-06	9.64e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SERPINE1—breast cancer	1.47e-06	9.63e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOTCH1—breast cancer	1.46e-06	9.58e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SRC—breast cancer	1.46e-06	9.54e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GPX1—breast cancer	1.45e-06	9.5e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BRAF—breast cancer	1.44e-06	9.44e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP1A1—breast cancer	1.44e-06	9.41e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APC—breast cancer	1.43e-06	9.37e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—breast cancer	1.43e-06	9.37e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—breast cancer	1.43e-06	9.36e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTEN—breast cancer	1.43e-06	9.34e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MTHFR—breast cancer	1.43e-06	9.34e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ERCC2—breast cancer	1.43e-06	9.33e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGF—breast cancer	1.42e-06	9.26e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—breast cancer	1.41e-06	9.22e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—breast cancer	1.41e-06	9.22e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—breast cancer	1.41e-06	9.2e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1—breast cancer	1.41e-06	9.19e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—breast cancer	1.41e-06	9.19e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT2—breast cancer	1.4e-06	9.19e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CD—breast cancer	1.38e-06	9.04e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAPK3—breast cancer	1.37e-06	8.95e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—breast cancer	1.36e-06	8.93e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CD—breast cancer	1.35e-06	8.83e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—BRAF—breast cancer	1.35e-06	8.8e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK3—breast cancer	1.34e-06	8.79e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MTHFR—breast cancer	1.34e-06	8.77e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SERPINE1—breast cancer	1.33e-06	8.73e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MDM2—breast cancer	1.33e-06	8.72e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KRAS—breast cancer	1.33e-06	8.71e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MYC—breast cancer	1.33e-06	8.7e-06	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—breast cancer	1.33e-06	8.7e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RAF1—breast cancer	1.33e-06	8.69e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CD—breast cancer	1.33e-06	8.69e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—breast cancer	1.33e-06	8.68e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RELA—breast cancer	1.32e-06	8.65e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAV1—breast cancer	1.32e-06	8.61e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ERBB2—breast cancer	1.31e-06	8.6e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—breast cancer	1.31e-06	8.58e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT2—breast cancer	1.31e-06	8.57e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—breast cancer	1.31e-06	8.54e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CB—breast cancer	1.3e-06	8.51e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—breast cancer	1.3e-06	8.51e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CB—breast cancer	1.3e-06	8.49e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MTOR—breast cancer	1.3e-06	8.49e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—breast cancer	1.29e-06	8.43e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—breast cancer	1.28e-06	8.36e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—breast cancer	1.27e-06	8.34e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CD—breast cancer	1.26e-06	8.23e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.26e-06	8.23e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—breast cancer	1.25e-06	8.2e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL8—breast cancer	1.25e-06	8.15e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SERPINE1—breast cancer	1.24e-06	8.14e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAV1—breast cancer	1.24e-06	8.09e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KRAS—breast cancer	1.23e-06	8.04e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PIK3CA—breast cancer	1.22e-06	8e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1B—breast cancer	1.22e-06	7.96e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MDM2—breast cancer	1.21e-06	7.91e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KRAS—breast cancer	1.21e-06	7.9e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CB—breast cancer	1.2e-06	7.88e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RAF1—breast cancer	1.2e-06	7.88e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RELA—breast cancer	1.2e-06	7.85e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CG—breast cancer	1.2e-06	7.84e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—breast cancer	1.19e-06	7.81e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—breast cancer	1.19e-06	7.8e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ERBB2—breast cancer	1.19e-06	7.8e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—breast cancer	1.19e-06	7.79e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—breast cancer	1.19e-06	7.78e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CB—breast cancer	1.18e-06	7.69e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MTOR—breast cancer	1.18e-06	7.69e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—breast cancer	1.16e-06	7.6e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUN—breast cancer	1.16e-06	7.58e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CB—breast cancer	1.16e-06	7.57e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CTNNB1—breast cancer	1.15e-06	7.52e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—breast cancer	1.15e-06	7.5e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—breast cancer	1.13e-06	7.4e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL8—breast cancer	1.13e-06	7.39e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PIK3CA—breast cancer	1.13e-06	7.39e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MDM2—breast cancer	1.13e-06	7.38e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—breast cancer	1.13e-06	7.38e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CG—breast cancer	1.13e-06	7.37e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTEN—breast cancer	1.12e-06	7.36e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RAF1—breast cancer	1.12e-06	7.35e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1A—breast cancer	1.12e-06	7.35e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTEN—breast cancer	1.12e-06	7.33e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERBB2—breast cancer	1.11e-06	7.27e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PIK3CA—breast cancer	1.11e-06	7.25e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1B—breast cancer	1.1e-06	7.22e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CB—breast cancer	1.1e-06	7.18e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTOR—breast cancer	1.1e-06	7.18e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK8—breast cancer	1.1e-06	7.17e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—breast cancer	1.1e-06	7.16e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—breast cancer	1.08e-06	7.08e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—breast cancer	1.08e-06	7.08e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—breast cancer	1.08e-06	7.07e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—breast cancer	1.06e-06	6.92e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CD—breast cancer	1.05e-06	6.9e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—breast cancer	1.05e-06	6.89e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUN—breast cancer	1.05e-06	6.87e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—breast cancer	1.04e-06	6.83e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CTNNB1—breast cancer	1.04e-06	6.82e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTEN—breast cancer	1.04e-06	6.81e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—breast cancer	1.04e-06	6.81e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SRC—breast cancer	1.04e-06	6.8e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1B—breast cancer	1.03e-06	6.74e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—breast cancer	1.03e-06	6.71e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—breast cancer	1.02e-06	6.69e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1A—breast cancer	1.02e-06	6.66e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTEN—breast cancer	1.02e-06	6.65e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—breast cancer	1.01e-06	6.62e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CA—breast cancer	1.01e-06	6.59e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—breast cancer	1e-06	6.56e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTEN—breast cancer	1e-06	6.54e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—breast cancer	1e-06	6.54e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—breast cancer	9.99e-07	6.54e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—breast cancer	9.95e-07	6.51e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK8—breast cancer	9.94e-07	6.5e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CD—breast cancer	9.9e-07	6.48e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—breast cancer	9.82e-07	6.42e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—breast cancer	9.78e-07	6.4e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CTNNB1—breast cancer	9.73e-07	6.36e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK3—breast cancer	9.58e-07	6.26e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1A—breast cancer	9.5e-07	6.22e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTEN—breast cancer	9.48e-07	6.2e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SRC—breast cancer	9.42e-07	6.17e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—breast cancer	9.35e-07	6.12e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MYC—breast cancer	9.31e-07	6.09e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—breast cancer	9.29e-07	6.08e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—breast cancer	9.22e-07	6.03e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CB—breast cancer	9.19e-07	6.01e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—breast cancer	9.18e-07	6.01e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—breast cancer	9.11e-07	5.96e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—breast cancer	9.09e-07	5.95e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—breast cancer	9.06e-07	5.93e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SRC—breast cancer	8.79e-07	5.75e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK3—breast cancer	8.68e-07	5.68e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CB—breast cancer	8.63e-07	5.65e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KRAS—breast cancer	8.61e-07	5.63e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—breast cancer	8.55e-07	5.6e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—breast cancer	8.48e-07	5.55e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MYC—breast cancer	8.45e-07	5.53e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—breast cancer	8.42e-07	5.51e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—breast cancer	8.26e-07	5.4e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—breast cancer	8.23e-07	5.38e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAPK3—breast cancer	8.1e-07	5.3e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PTEN—breast cancer	7.94e-07	5.19e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CA—breast cancer	7.93e-07	5.19e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CA—breast cancer	7.91e-07	5.17e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MYC—breast cancer	7.88e-07	5.15e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—breast cancer	7.86e-07	5.14e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KRAS—breast cancer	7.8e-07	5.11e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—breast cancer	7.71e-07	5.04e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—breast cancer	7.65e-07	5e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTEN—breast cancer	7.46e-07	4.88e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CA—breast cancer	7.34e-07	4.8e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—breast cancer	7.31e-07	4.79e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KRAS—breast cancer	7.28e-07	4.76e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CA—breast cancer	7.17e-07	4.69e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CA—breast cancer	7.06e-07	4.62e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—breast cancer	7e-07	4.58e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—breast cancer	6.94e-07	4.54e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CA—breast cancer	6.69e-07	4.38e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—breast cancer	6.63e-07	4.34e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—breast cancer	6.48e-07	4.24e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—breast cancer	6.46e-07	4.23e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—breast cancer	6.35e-07	4.15e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—breast cancer	6.19e-07	4.05e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—breast cancer	6e-07	3.92e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—breast cancer	5.92e-07	3.87e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—breast cancer	5.86e-07	3.83e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—breast cancer	5.76e-07	3.77e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CA—breast cancer	5.6e-07	3.66e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—breast cancer	5.46e-07	3.57e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CA—breast cancer	5.26e-07	3.44e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—breast cancer	4.58e-07	2.99e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—breast cancer	4.3e-07	2.81e-06	CbGpPWpGaD
